RAPT Therapeutics Inc
|Market Cap (Intraday)||461.44M|
|2yr Forward PE||N/A|
RAPT Therapeutics Inc Stock, NASDAQ:RAPT
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.